Status:
COMPLETED
Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Depressive Disorder, Major
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The primary objective is to compare the antidepressant efficacy, safety, and tolerability of DVS SR versus placebo in subjects with Major Depressive Disorder. Additional objectives include testing bot...
Eligibility Criteria
Inclusion
- A primary diagnosis of MDD
- Depressive symptoms for at least 30 days before the screening visit.
Exclusion
- Treatment with DVS SR at any time in the past.
- Known hypersensitivity to venlafaxine
- Significant risk of suicide based on clinical judgment
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2007
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00300378
Start Date
March 1 2006
End Date
January 1 2007
Last Update
December 5 2007
Active Locations (43)
Enter a location and click search to find clinical trials sorted by distance.
1
Rijeka, Croatia, 51000
2
Split, Croatia, 21000
3
Zagreb, Croatia, 10090
4
Tallinn, Estonia, 126 18